Close Menu

23andMe Pledges QC

23andMe took to its blog, The Spittoon, yesterday to provide a public update on the recent sample switch-up at its contracted partner, LabCorp. The DTC firm confirms that "the processing mistake was caused by human error and the incorrect placement of a single 96-well plate used in processing samples." 23andMe writes that, along with their contracted laboratory, they are taking measures to prevent future mix-ups.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.